日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Orally Bioavailable and Site-Selective Covalent STING Inhibitor Derived from a Macrocyclic Marine Diterpenoid

一种源自大环海洋二萜类化合物的口服生物利用度高且具有位点选择性的共价STING抑制剂

Guang-Hao Niu ,Wan-Chi Hsiao ,Po-Hsun Lee ,Li-Guo Zheng ,Yu-Shao Yang ,Wei-Cheng Huang ,Chih-Chien Hsieh ,Tai-Yu Chiu ,Jing-Ya Wang ,Ching-Ping Chen ,Chen-Lung Huang ,May-Su You ,Yi-Ping Kuo ,Chien-Ming Wang ,Zhi-Hong Wen ,Guann-Yi Yu ,Chiung-Tong Chen ,Ya-Hui Chi ,Chun-Wei Tung ,Shu-Ching Hsu ,Teng-Kuang Yeh ,Ping-Jyun Sung ,Mingzi M Zhang ,Lun Kelvin Tsou

Simvastatin Attenuates Areca Nut Extract-Induced Subdermal Fibrosis in Mice by Targeting TGF-β Signaling Pathways

辛伐他汀通过靶向TGF-β信号通路减轻槟榔提取物诱导的小鼠皮下纤维化

Chang, Chi-Hua; Lin, Ching-Ping; Chen, Yuk-Kwan; Hsiao, Yu-Fang; Wang, Yan-Hsiung

Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies

血液系统恶性肿瘤患者接种新冠加强疫苗的血清学反应及预测因素

Huang, Chien-Tzu; Lee, Ching-Ping; Chen, Tzu-Yin; Liu, Yi-Chang; Cho, Shih-Feng; Du, Jeng-Shiun; Yu, Ming-Lung; Huang, Chung-Feng; Wang, Sheng-Fan; Hsiao, Hui-Hua

Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins

发现并合成基于嘧啶的 Aurora 激酶抑制剂以降低 MYC 癌蛋白的水平

Ya-Hui Chi, Teng-Kuang Yeh, Yi-Yu Ke, Wen-Hsing Lin, Chia-Hua Tsai, Wan-Ping Wang, Yen-Ting Chen, Yu-Chieh Su, Pei-Chen Wang, Yan-Fu Chen, Zhong-Wei Wu, Jen-Yu Yeh, Ming-Chun Hung, Mine-Hsine Wu, Jing-Ya Wang, Ching-Ping Chen, Jen-Shin Song, Chuan Shih, Chiung-Tong Chen, Chun-Ping Chang

BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy

BPRDP056,一种专门针对磷脂酰丝氨酸的新型小分子药物偶联物,用于癌症治疗

Yun-Yu Chen, Chen-Fu Lo, Tai-Yu Chiu, Chia-Yu Hsu, Teng-Kuang Yeh, Ching-Ping Chen, Chen-Lung Huang, Chung-Yu Huang, Min-Hsien Wang, Yu-Chen Huang, Hsuan-Hui Ho, Yu-Sheng Chao, Joe C Shih, Lun K Tsou, Chiung-Tong Chen

Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System

脂肪乳对纳米药物 Abraxane 疗法和先天免疫系统的影响

Yen-Ju Chen #, Chin-Yi Tsai #, Ying-Min Cheng, Su-Wen Nieh, Teng-Kuang Yeh, Ching- Ping Chen, Min-Hsien Wang, Ling-Hui Chou, Tai-Yu Chiu, Li Liu, Chien Ho, Chiung- Tong Chen, Tsang-Wu Liu

Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation

发现用于治疗 AML 和实体肿瘤的喹唑啉类多激酶抑制剂 BPR1K871:合理设计、合成、体外和体内评估

Yung Chang Hsu, Mohane Selvaraj Coumar, Wen-Chieh Wang, Hui-Yi Shiao, Yi-Yu Ke, Wen-Hsing Lin, Ching-Chuan Kuo, Chun-Wei Chang, Fu-Ming Kuo, Pei-Yi Chen, Sing-Yi Wang, An-Siou Li, Chun-Hwa Chen, Po-Chu Kuo, Ching-Ping Chen, Ming-Hsine Wu, Chen-Lung Huang, Kuei-Jung Yen, Yun-I Chang, John T-A Hsu, Ch

Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancer

评估 BPR1J-340(一种强效选择性 FLT3 抑制剂)单独使用或与 HDAC 抑制剂伏立诺他联合使用对 AML 癌症的抗肿瘤作用

Wen-Hsing Lin, Teng-Kuang Yeh, Weir-Torn Jiaang, Kuei-Jung Yen, Chun-Hwa Chen, Chin-Ting Huang, Shih-Chieh Yen, Shu-Yi Hsieh, Ling-Hui Chou, Ching-Ping Chen, Chun-Hsien Chiu, Li-Chun Kao, Yu-Sheng Chao, Chiung-Tong Chen, John T-A Hsu

Characterization of Niemann-Pick Type C2 protein expression in multiple cancers using a novel NPC2 monoclonal antibody

利用新型NPC2单克隆抗体对多种癌症中尼曼-匹克C型蛋白的表达进行表征

Liao, Yi-Jen; Lin, Meng-Wei; Yen, Chia-Hung; Lin, Yu-Ting; Wang, Chung-Kwe; Huang, Shiu-Feng; Chen, Kuan-Hsuan; Yang, Ching-Ping; Chen, Tzu-Lang; Hou, Ming-Feng; Arthur Chen, Yi-Ming

Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules

Aurora 激酶抑制剂揭示 HURP 在着丝粒和着丝粒微管成核中的机制

Jiun-Ming Wu, Chiung-Tong Chen, Mohane Selvaraj Coumar, Wen-Hsin Lin, Zi-Jie Chen, John T-A Hsu, Yi-Hui Peng, Hui-Yi Shiao, Wen-Hsing Lin, Chang-Ying Chu, Jian-Sung Wu, Chih-Tsung Lin, Ching-Ping Chen, Ching-Cheng Hsueh, Kai-Yen Chang, Li-Pin Kao, Chi-Ying F Huang, Yu-Sheng Chao, Su-Ying Wu, Hsing-P